CR, complete response; ISS, International Staging System; NE, not evaluable; PD, progressive disease; SD, stable disease; VGPR, very good partial response. *Excluded were three patients not evaluable
IPT-weighted cumulative incidence and SHRs in the intention-to-treat analysis for factor Xa inhibitor cohort versus the dabigatran cohort during 5 years of follow-up.